Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer

被引:82
作者
Kim, Tae-Dong
Song, Kyoung-Sub
Li, Ge
Choi, Hoon
Park, Hae-Duck
Lim, Kyu
Hwang, Byung-Doo
Yoon, Wan-Hee [1 ]
机构
[1] Chungnam Natl Univ, Coll Med, Dept Surg, Taejon 301721, South Korea
[2] Chungnam Natl Univ, Coll Med, Dept Biochem, Taejon 301721, South Korea
[3] Chungnam Natl Univ, Canc Res Inst, Taejon 301721, South Korea
关键词
D O I
10.1186/1471-2407-6-211
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Matrix metalloproteinase-2 (MMP-2), matrix metalloproteinase-9 (MMP-9), and urokinase-type plasminogen activator (uPA) are involved in colorectal cancer invasion and metastasis. There is still debate whether the activity of MMP-2 and MMP-9 differs between tumors located in the colon and rectum. We designed this study to determine any differences in the expression of MMP-2, MMP-9 and uPA system between colon and rectal cancer tissues. Methods: Cancer tissue samples were obtained from colon carcinoma (n = 12) and rectal carcinomas ( n = 10). MMP-2 and MMP-9 levels were examined using gelatin zymography and Western blotting; their endogenous inhibitors, tissue inhibitor of metalloproteinase-2 (TIMP-2) and tissue inhibitor of metalloproteinase-1 (TIMP-1), were assessed by Western blotting. uPA, uPAR and PAI-1 were examined using enzyme-linked immunosorbent assay ( ELISA). The activity of uPA was assessed by casein-plasminogen zymography. Results: In both colon and rectal tumors, MMP-2, MMP-9 and TIMP-1 protein levels were higher than in corresponding paired normal mucosa, while TIMP-2 level in tumors was significantly lower than in normal mucosa. The enzyme activities or protein levels of MMP-2, MMP-9 and their endogenous inhibitors did not reach a statistically significant difference between colon and rectal cancer compared with their normal mucosa. In rectal tumors, there was an increased activity of uPA compared with the activity in colon tumors ( P = 0.0266), however urokinase-type plasminogen activator receptor ( uPAR) and plasminogen activator inhibitor-1 (PAI-1) showed no significant difference between colon and rectal cancer tissues. Conclusion: These findings suggest that uPA may be expressed differentially in colon and rectal cancers, however, the activities or protein levels of MMP-2, MMP-9, TIMP-1, TIMP-2, PAI-1 and uPAR are not affected by tumor location in the colon or the rectum.
引用
收藏
页数:11
相关论文
共 36 条
[1]  
Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO
[2]  
2-Z
[3]   The plasminogen activator and matrix metalloproteinase systems in colorectal cancer: relationship to tumour pathology [J].
Baker, EA ;
Leaper, DJ .
EUROPEAN JOURNAL OF CANCER, 2003, 39 (07) :981-988
[4]   Plasmin/plasminogen system in colorectal cancer [J].
Berger, DH .
WORLD JOURNAL OF SURGERY, 2002, 26 (07) :767-771
[5]   uPAR: A versatile signalling orchestrator [J].
Blasi, F ;
Carmeliet, P .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2002, 3 (12) :932-943
[6]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[7]  
Costantini V, 1996, CANCER-AM CANCER SOC, V77, P1079, DOI 10.1002/(SICI)1097-0142(19960315)77:6<1079::AID-CNCR12>3.0.CO
[8]  
2-Z
[9]  
DAHIYA R, 1992, BIOCHEM INT, V27, P567
[10]   Differential expression of cyclooxygenase 2 in human colorectal cancer [J].
Dimberg, J ;
Samuelsson, A ;
Hugander, A ;
Söderkvist, P .
GUT, 1999, 45 (05) :730-732